Stock Track | TYK MEDICINES-B Soars 7.26% Intraday on Strong Annual Results and Upcoming AACR Presentation

Stock Track04-01

TYK MEDICINES-B's stock surged 7.26% during intraday trading on Wednesday, driven by the release of its annual financial results and a significant research announcement.

The company recently disclosed its annual report for the period ending December 31, 2025, which showed a year-on-year increase in R&D investment and other income. More notably, TYK MEDICINES-B announced that it will present research progress for five of its self-developed small-molecule anti-tumor drug candidates at the poster session of the upcoming 2026 American Association for Cancer Research (AACR) Annual Meeting.

The announcement regarding the presentation of multiple innovative drug candidates at a major international oncology conference appears to have bolstered investor confidence in the company's research pipeline and future growth potential.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1182188038?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-01 12:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1182188038","market":"hk","top_or_hot":-1,"title":"Stock Track | TYK MEDICINES-B Soars 7.26% Intraday on Strong Annual Results and Upcoming AACR Presentation","media":"Stock Track","content":"<p>TYK MEDICINES-B's stock surged 7.26% during intraday trading on Wednesday, driven by the release of its annual financial results and a significant research announcement.</p><p>The company recently disclosed its annual report for the period ending December 31, 2025, which showed a year-on-year increase in R&D investment and other income. More notably, TYK MEDICINES-B announced that it will present research progress for five of its self-developed small-molecule anti-tumor drug candidates at the poster session of the upcoming 2026 American Association for Cancer Research (AACR) Annual Meeting.</p><p>The announcement regarding the presentation of multiple innovative drug candidates at a major international oncology conference appears to have bolstered investor confidence in the company's research pipeline and future growth potential.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | TYK MEDICINES-B Soars 7.26% Intraday on Strong Annual Results and Upcoming AACR Presentation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | TYK MEDICINES-B Soars 7.26% Intraday on Strong Annual Results and Upcoming AACR Presentation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-01 12:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TYK MEDICINES-B's stock surged 7.26% during intraday trading on Wednesday, driven by the release of its annual financial results and a significant research announcement.</p><p>The company recently disclosed its annual report for the period ending December 31, 2025, which showed a year-on-year increase in R&D investment and other income. More notably, TYK MEDICINES-B announced that it will present research progress for five of its self-developed small-molecule anti-tumor drug candidates at the poster session of the upcoming 2026 American Association for Cancer Research (AACR) Annual Meeting.</p><p>The announcement regarding the presentation of multiple innovative drug candidates at a major international oncology conference appears to have bolstered investor confidence in the company's research pipeline and future growth potential.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02410","symbol_name":"同源康医药-B","start_time":0,"source_url":"","article_id":"1182188038","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1182188038","pubTimestamp":1775019445,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"TYK MEDICINES-B's stock surged 7.26% during intraday trading on Wednesday, driven by the release of its annual financial results and a significant research announcement.The company recently disclosed...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02410":"同源康医药-B"},"translate_title":"个股追踪|TYK MEDICINES-B盘中飙升7.26%，得益于强劲的年度业绩和即将举行的AACR演示","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02410":1},"content_text":"TYK MEDICINES-B's stock surged 7.26% during intraday trading on Wednesday, driven by the release of its annual financial results and a significant research announcement.The company recently disclosed its annual report for the period ending December 31, 2025, which showed a year-on-year increase in R&D investment and other income. More notably, TYK MEDICINES-B announced that it will present research progress for five of its self-developed small-molecule anti-tumor drug candidates at the poster session of the upcoming 2026 American Association for Cancer Research (AACR) Annual Meeting.The announcement regarding the presentation of multiple innovative drug candidates at a major international oncology conference appears to have bolstered investor confidence in the company's research pipeline and future growth potential.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1182188038","isCrawlerRequest":true}